Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach ...

Tarsus Pharmaceuticals Inc. closed an upsized $134.8 million public offering this month.The Irvine-based biopharmaceutical ...

Rosacea and eczema are two common skin conditions with similar symptoms, such as itching, bumps, and skin discoloration. However, some key differences can help tell them apart. Eczema refers to a ...

Investigators sought to better understand how race and ethnicity was related to the severity of rosacea phenotypes among adults.

Patients with atopic dermatitis are primed to have more severe symptoms from ocular surface disease. Individuals with atopic dermatitis (AD), both active and prior cases, have a higher prevalence of ...

Some people experience eye symptoms, including redness, irritation, and swollen eyelids, known as ocular rosacea. While the exact cause is unknown, factors such as genetics, immune system response ...

For those with rosacea, this isn’t just an occasional flush; it’s a daily struggle. Rosacea is a skin condition that causes persistent redness, sensitivity, and unexpected flare-ups.

A Phase II study for ocular rosacea is set to begin in late 2025, with data expected in 2026. Tarsus aims to expand physician education to identify Demodex blepharitis in broader patient categories.